8q24 sequence variants in relation to prostate cancer risk among men of African descent: A case-control study

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Benford, Marnita L ^a,b   VanCleave, Tiva T ^a,b   Lavender, Nicole A ^a,b   Kittles, Rick A ^c   Kidd, LaCreis R ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; AUTOSOMAL INHERITANCE; CANCER RISK; CHROMOSOME 8Q; CHROMOSOME ANALYSIS; CHROMOSOME VARIANT; CONTROLLED STUDY; GENE FREQUENCY; GENE TARGETING; GENETIC ASSOCIATION; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PROSTATE CANCER; SEQUENCE ANALYSIS; CANCER STAGING; CASE CONTROL STUDY; CHROMOSOME 8; COMPARATIVE STUDY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GENOTYPE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; RISK FACTOR; SURVIVAL RATE;

DNA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; DNA; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTORS; SURVIVAL RATE;

EID: 77953935070     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-334     Document Type: Article

References (29)

1. American Cancer Society Cancer Facts & Figures 2009. Atlanta, Amerian Cancer Society, American Cancer Society.
2. American Cancer Society Cancer Facts & Figure for African Americans 2009-2010. Atlanta, Amerian Cancer Society, American Cancer Society.
3. Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, Stanford JL. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. Cancer EpidemiolBiomarkers Prev 2008, 17(5):1203-1213.
4. Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, Zheng SL, Sun J, Isaacs SD, Wiley KE, Kim ST, et al. Prostate cancer risk associated loci in African Americans. Cancer EpidemiolBiomarkers Prev 2009, 18(7):2145-2149.
5. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, et al. A common variant associated with prostate cancer in European and African populations. NatGenet 2006, 38(6):652-658.
6. Robbins C, Torres JB, Hooker S, Bonilla C, Hernandez W, Candreva A, Ahaghotu C, Kittles R, Carpten J. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 2007, 17(12):1717-1722. 10.1101/gr.6782707, 2099580, 17978284.
7. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, Rafnar T, Bergthorsson JT, Agnarsson BA, Baker A, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. NatGenet 2007, 39(5):631-637.
8. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. NatGenet 2007, 39(5):638-644.
9. Cussenot O, Azzouzi AR, Bantsimba-Malanda G, Gaffory C, Mangin P, Cormier L, Fournier G, Valeri A, Jouffe L, Roupret M, et al. Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer. ClinCancer Res 2008, 14(17):5635-5639.
10. Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. ClinCancer Res 2009, 15(9):3231-3237.
11. Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, et al. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. JNatlCancer Inst 2007, 99(20):1525-1533.
12. Raja J, Ramachandran N, Munneke G, Patel U. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol 2006, 61(2):142-153. 10.1016/j.crad.2005.10.002, 16439219.
13. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966, 50(3):125-128.
14. National Center for Biotechnology Information (NCBI) website. , http://www.ncbi.nlm.nih.gov/
15. Tian C, Hinds DA, Shigeta R, Kittles R, Ballinger DG, Seldin MF. A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. AmJHumGenet 2006, 79(4):640-649.
16. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003, 19(3):376-382. 10.1093/bioinformatics/btf869, 12584123.
17. Multi-factor dimensionality reduction. , http://www.epistasis.org
18. Park SL, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, Hussain SK, Jiang Q, Liu S, Lu ML, et al. Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. Cancer EpidemiolBiomarkers Prev 2008, 17(11):3193-3202.
19. Cheng I, Plummer SJ, Jorgenson E, Liu X, Rybicki BA, Casey G, Witte JS. 8q24 and prostate cancer: association with advanced disease and meta-analysis. EurJHumGenet 2008, 16(4):496-505.
20. SNP500Cancer database. , http://snp500cancer.nci.nih.gov/
21. Schumacher FR, Feigelson HS, Cox DG, Haiman CA, Albanes D, Buring J, Calle EE, Chanock SJ, Colditz GA, Diver WR, et al. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 2007, 67(7):2951-2956. 10.1158/0008-5472.CAN-06-3591, 17409400.
22. Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, Debniak T, Matyjasik J, Mierzejewski M, Medrek K, Oszutowska D, et al. A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res 2008, 68(23):9982-9986. 10.1158/0008-5472.CAN-08-1838, 19047180.
23. Severi G, Hayes VM, Padilla EJ, English DR, Southey MC, Sutherland RL, Hopper JL, Giles GG. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study. Cancer EpidemiolBiomarkers Prev 2007, 16(3):610-612.
24. Wang L, McDonnell SK, Slusser JP, Hebbring SJ, Cunningham JM, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 2007, 67(7):2944-2950. 10.1158/0008-5472.CAN-06-3186, 17409399.
25. Suuriniemi M, Agalliu I, Schaid DJ, Johanneson B, McDonnell SK, Iwasaki L, Stanford JL, Ostrander EA. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer EpidemiolBiomarkers Prev 2007, 16(4):809-814.
26. Loeb S, Catalona WJ. What is the prognostic impact of positive surgical margins in surgically treated prostate cancer?. Nat Clin Pract Urol 2006, 3(8):418-419. 10.1038/ncpuro0549, 16902516.
27. Shriver MD, Kittles RA. Genetic ancestry and the search for personalized genetic histories. NatRevGenet 2004, 5(8):611-618.
28. Kittles RA, Chen W, Panguluri RK, Ahaghotu C, Jackson A, Adebamowo CA, Griffin R, Williams T, Ukoli F, ms-Campbell L, et al. CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification?. HumGenet 2002, 110(6):553-560.
29. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992, 23(3):273-279. 10.1016/0046-8177(92)90108-F, 1555838.